Listed by the USPTO as KIM, SEONG JONG
Tech Center 1600 • Art Units: 1621 1623 1627 1628 1641 1693
This examiner grants 25% of resolved cases
KIM, SEONG JONG is assigned to tech center 1600 and art unit 1621. The profile contains 4 resolved cases, with an allowance rate of 25.0%. The median time to allowance is 997 days, and interviews are associated with a 0.0% lift.
The listed companies are Convelo Therapeutics Inc., Antecip Bioventures Ii LLC, and Bristol-Myers Squibb Company. The listed firms are ALSTON & BIRD LLP, FisherBroyles, LLP, and JCIPRNET. Because the record contains only 4 resolved cases, the figures provide limited historical context for broad prosecution conclusions. Counsel may still use the profile to identify the assigned art unit and to account for the recorded allowance timing.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18923576 | TREATMENT OF DEPRESSION | Non-Final OA | ANTECIP BIOVENTURES II LLC |
| 18947116 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18292046 | WATER SOLUBLE PRODRUG, CONJUGATES AND USES THEREOF | Non-Final OA | MERCK PATENT GMBH |
| 18897766 | SPECIFIC TETRADENTATE COPPER CHELATORS AS ANTICANCER AGENTS | Non-Final OA | Centre National de la Recherche Scientifique |
| 18687257 | METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE | Non-Final OA | The Regents of the University of California |
| 18287427 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS THROUGH INHIBITION OF CD44 AND FERM PROTEIN INTERACTION | Non-Final OA | Arizona Board of Regents on Behalf of the University of Arizona |
| 18254936 | STABILIZED COMPOSITIONS CONTAINING STROBILURIN FUNGICIDES AND POLYHYDRIC ALCOHOLS | Final Rejection | ADAMA MAKHTESHIM LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy25.0% of resolved applications examined by Seong Jong Kim were allowed (4 resolved cases), compared with 46.0% across Art Unit 1621 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Seong Jong Kim took 997 days on average from filing to allowance.
Seong Jong Kim examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
